GO and KEGG enrichment analyses further demonstrated that Fespixon cream targets are significantly involved in biological pathways associated with AGE-RAGE signaling, HIF-1 and VEGF signaling, and lipid metabolism and atherosclerosis—all of which are implicated in DFU pathogenesis. Here, RENBP is linked to atherosclerosis.